Division of Infection, Inflammation and Immunity, University of Southampton School of Medicine, Southampton, United Kingdom.
N Engl J Med. 2011 May 26;364(21):2006-15. doi: 10.1056/NEJMoa1014350.
Asthma is characterized pathologically by structural changes in the airway, termed airway remodeling. These changes are associated with worse long-term clinical outcomes and have been attributed to eosinophilic inflammation. In vitro studies indicate, however, that the compressive mechanical forces that arise during bronchoconstriction may induce remodeling independently of inflammation. We evaluated the influence of repeated experimentally induced bronchoconstriction on airway structural changes in patients with asthma.
We randomly assigned 48 subjects with asthma to one of four inhalation challenge protocols involving a series of three challenges with one type of inhaled agent presented at 48-hour intervals. The two active challenges were with either a dust-mite allergen (which causes bronchoconstriction and eosinophilic inflammation) or methacholine (which causes bronchoconstriction without eosinophilic inflammation); the two control challenges (neither of which causes bronchoconstriction) were either saline alone or albuterol followed by methacholine (to control for nonbronchoconstrictor effects of methacholine). Bronchial-biopsy specimens were obtained before and 4 days after completion of the challenges.
Allergen and methacholine immediately induced similar levels of bronchoconstriction. Eosinophilic inflammation of the airways increased only in the allergen group, whereas both the allergen and the methacholine groups had significant airway remodeling not seen in the two control groups. Subepithelial collagen-band thickness increased by a median of 2.17 μm in the allergen group (interquartile range [IQR], 0.70 to 3.67) and 1.94 μm in the methacholine group (IQR, 0.37 to 3.24) (P<0.001 for the comparison of the two challenge groups with the two control groups); periodic acid-Schiff staining of epithelium (mucus glands) also increased, by a median of 2.17 percentage points in the allergen group (IQR, 1.03 to 4.77) and 2.13 percentage points in the methacholine group (IQR, 1.14 to 7.96) (P=0.003 for the comparison with controls). There were no significant differences between the allergen and methacholine groups.
Bronchoconstriction without additional inflammation induces airway remodeling in patients with asthma. These findings have potential implications for management.
哮喘的病理特征为气道结构发生改变,即气道重塑。这些变化与长期临床预后较差有关,被归因于嗜酸性粒细胞炎症。然而,体外研究表明,在支气管收缩期间产生的压缩机械力可能会独立于炎症引起重塑。我们评估了反复进行的实验性支气管收缩对哮喘患者气道结构变化的影响。
我们将 48 名哮喘患者随机分配到四个吸入挑战方案之一,该方案涉及在 48 小时间隔内进行三次吸入剂挑战,每次使用一种吸入剂。两种活性挑战分别是尘螨过敏原(引起支气管收缩和嗜酸性粒细胞炎症)或乙酰甲胆碱(引起支气管收缩而无嗜酸性粒细胞炎症);两种对照挑战(均不引起支气管收缩)分别是单独生理盐水或沙丁胺醇后乙酰甲胆碱(控制乙酰甲胆碱的非支气管收缩作用)。在完成挑战后 4 天,获取支气管活检标本。
过敏原和乙酰甲胆碱立即引起相似程度的支气管收缩。气道中的嗜酸性粒细胞炎症仅在过敏原组中增加,而过敏原和乙酰甲胆碱组均发生了对照两组中未见的显著气道重塑。上皮下胶原带厚度中位数在过敏原组中增加了 2.17μm(四分位距[IQR],0.70 至 3.67),在乙酰甲胆碱组中增加了 1.94μm(IQR,0.37 至 3.24)(两组挑战与两组对照相比,P<0.001);上皮(粘液腺)的过碘酸-希夫染色也增加,过敏原组中位数增加了 2.17 个百分点(IQR,1.03 至 4.77),乙酰甲胆碱组增加了 2.13 个百分点(IQR,1.14 至 7.96)(与对照组相比,P=0.003)。过敏原组和乙酰甲胆碱组之间无显著差异。
无额外炎症的支气管收缩可引起哮喘患者气道重塑。这些发现对管理具有潜在意义。